Tff Cash Flow To Debt Ratio vs Cash Per Share Analysis

TFFP Stock

USD 0.34 0.03 9.68%

Tff Pharmaceuticals financial indicator trend analysis is much more than just breaking down Tff Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tff Pharmaceuticals is a good investment. Please check the relationship between Tff Pharmaceuticals Cash Flow To Debt Ratio and its Cash Per Share accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tff Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.

Cash Flow To Debt Ratio vs Cash Per Share

Cash Flow To Debt Ratio vs Cash Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tff Pharmaceuticals Cash Flow To Debt Ratio account and Cash Per Share. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Tff Pharmaceuticals' Cash Flow To Debt Ratio and Cash Per Share is -0.31. Overlapping area represents the amount of variation of Cash Flow To Debt Ratio that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of Tff Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Tff Pharmaceuticals' Cash Flow To Debt Ratio and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Flow To Debt Ratio of Tff Pharmaceuticals are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Cash Flow To Debt Ratio i.e., Tff Pharmaceuticals' Cash Flow To Debt Ratio and Cash Per Share go up and down completely randomly.

Correlation Coefficient

-0.31

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cash Flow To Debt Ratio

Cash Per Share

Most indicators from Tff Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tff Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tff Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.As of 11/30/2024, Selling General Administrative is likely to drop to about 6.8 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 4.8 M

Tff Pharmaceuticals fundamental ratios Correlations

	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Total Liab	Common Stock Shares Outstanding	Non Current Liabilities Total	Net Invested Capital	Net Working Capital	Other Current Liab	Net Debt	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Deferred Long Term Liab	Capital Stock	Common Stock	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Retained Earnings Total Equity	Property Plant And Equipment Gross
Total Current Liabilities		0.56	0.87	-0.9	0.84	0.88	-0.78	0.22	0.51	0.47	0.37	-0.18	-0.71	0.18	0.83	0.83	0.7	0.86	-0.71	-0.8	0.28	-0.71	0.65	0.69	-0.81	0.65
Total Stockholder Equity	0.56		0.74	-0.45	0.88	0.74	-0.84	0.79	0.98	0.99	-0.51	-0.9	0.03	0.9	0.79	0.74	0.85	0.66	0.03	-0.82	0.83	0.03	0.36	0.28	-0.47	0.36
Net Tangible Assets	0.87	0.74		-0.91	0.88	0.87	-0.97	0.4	0.77	0.65	0.06	-0.42	-0.58	0.42	0.97	0.94	0.86	0.95	-0.58	-0.98	0.57	-0.58	0.73	0.74	-0.81	0.73
Retained Earnings	-0.9	-0.45	-0.91		-0.75	-0.79	0.8	-0.02	-0.47	-0.33	-0.32	0.05	0.72	-0.05	-0.87	-0.89	-0.65	-0.95	0.72	0.83	-0.37	0.72	-0.88	-0.92	0.92	-0.88
Accounts Payable	0.84	0.88	0.88	-0.75		0.87	-0.87	0.52	0.86	0.82	-0.13	-0.64	-0.29	0.64	0.91	0.91	0.91	0.87	-0.29	-0.88	0.68	-0.29	0.58	0.56	-0.73	0.58
Total Liab	0.88	0.74	0.87	-0.79	0.87		-0.88	0.48	0.69	0.68	0.07	-0.42	-0.43	0.42	0.91	0.89	0.7	0.86	-0.43	-0.88	0.47	-0.43	0.56	0.61	-0.7	0.56
Common Stock Shares Outstanding	-0.78	-0.84	-0.97	0.8	-0.87	-0.88		-0.57	-0.86	-0.78	0.13	0.58	0.42	-0.57	-0.97	-0.91	-0.86	-0.89	0.42	1.0	-0.68	0.42	-0.65	-0.64	0.71	-0.65
Non Current Liabilities Total	0.22	0.79	0.4	-0.02	0.52	0.48	-0.57		0.74	0.84	-0.55	-0.84	0.18	0.83	0.43	0.31	0.64	0.21	0.18	-0.54	0.53	0.18	-0.15	-0.17	0.11	-0.15
Net Invested Capital	0.51	0.98	0.77	-0.47	0.86	0.69	-0.86	0.74		0.96	-0.5	-0.9	0.01	0.9	0.81	0.76	0.87	0.68	0.01	-0.85	0.84	0.01	0.38	0.3	-0.49	0.38
Net Working Capital	0.47	0.99	0.65	-0.33	0.82	0.68	-0.78	0.84	0.96		-0.57	-0.94	0.12	0.94	0.71	0.65	0.8	0.56	0.12	-0.76	0.81	0.12	0.24	0.16	-0.36	0.24
Other Current Liab	0.37	-0.51	0.06	-0.32	-0.13	0.07	0.13	-0.55	-0.5	-0.57		0.7	-0.77	-0.71	-0.05	-0.02	-0.22	0.07	-0.77	0.1	-0.75	-0.77	0.06	0.19	-0.2	0.06
Net Debt	-0.18	-0.9	-0.42	0.05	-0.64	-0.42	0.58	-0.84	-0.9	-0.94	0.7		-0.35	-1.0	-0.49	-0.43	-0.67	-0.31	-0.35	0.55	-0.75	-0.35	0.01	0.11	0.11	0.01
Other Assets	-0.71	0.03	-0.58	0.72	-0.29	-0.43	0.42	0.18	0.01	0.12	-0.77	-0.35		0.36	-0.41	-0.39	-0.3	-0.49	1.0	0.45	0.26	1.0	-0.46	-0.54	0.55	-0.46
Cash And Short Term Investments	0.18	0.9	0.42	-0.05	0.64	0.42	-0.57	0.83	0.9	0.94	-0.71	-1.0	0.36		0.49	0.43	0.67	0.31	0.36	-0.55	0.76	0.36	-0.01	-0.11	-0.11	-0.01
Common Stock Total Equity	0.83	0.79	0.97	-0.87	0.91	0.91	-0.97	0.43	0.81	0.71	-0.05	-0.49	-0.41	0.49		0.99	0.84	0.97	-0.41	-0.97	0.65	-0.41	0.72	0.74	-0.8	0.72
Capital Surpluse	0.83	0.74	0.94	-0.89	0.91	0.89	-0.91	0.31	0.76	0.65	-0.02	-0.43	-0.39	0.43	0.99		0.8	0.99	-0.39	-0.92	0.64	-0.39	0.77	0.79	-0.85	0.77
Other Current Assets	0.7	0.85	0.86	-0.65	0.91	0.7	-0.86	0.64	0.87	0.8	-0.22	-0.67	-0.3	0.67	0.84	0.8		0.77	-0.3	-0.86	0.67	-0.3	0.49	0.46	-0.54	0.49
Other Stockholder Equity	0.86	0.66	0.95	-0.95	0.87	0.86	-0.89	0.21	0.68	0.56	0.07	-0.31	-0.49	0.31	0.97	0.99	0.77		-0.49	-0.9	0.59	-0.49	0.84	0.87	-0.9	0.84
Deferred Long Term Liab	-0.71	0.03	-0.58	0.72	-0.29	-0.43	0.42	0.18	0.01	0.12	-0.77	-0.35	1.0	0.36	-0.41	-0.39	-0.3	-0.49		0.45	0.26	1.0	-0.46	-0.54	0.55	-0.46
Capital Stock	-0.8	-0.82	-0.98	0.83	-0.88	-0.88	1.0	-0.54	-0.85	-0.76	0.1	0.55	0.45	-0.55	-0.97	-0.92	-0.86	-0.9	0.45		-0.66	0.45	-0.66	-0.66	0.73	-0.66
Common Stock	0.28	0.83	0.57	-0.37	0.68	0.47	-0.68	0.53	0.84	0.81	-0.75	-0.75	0.26	0.76	0.65	0.64	0.67	0.59	0.26	-0.66		0.26	0.55	0.43	-0.48	0.55
Other Liab	-0.71	0.03	-0.58	0.72	-0.29	-0.43	0.42	0.18	0.01	0.12	-0.77	-0.35	1.0	0.36	-0.41	-0.39	-0.3	-0.49	1.0	0.45	0.26		-0.46	-0.54	0.55	-0.46
Property Plant And Equipment Net	0.65	0.36	0.73	-0.88	0.58	0.56	-0.65	-0.15	0.38	0.24	0.06	0.01	-0.46	-0.01	0.72	0.77	0.49	0.84	-0.46	-0.66	0.55	-0.46		0.97	-0.91	1.0
Current Deferred Revenue	0.69	0.28	0.74	-0.92	0.56	0.61	-0.64	-0.17	0.3	0.16	0.19	0.11	-0.54	-0.11	0.74	0.79	0.46	0.87	-0.54	-0.66	0.43	-0.54	0.97		-0.88	0.97
Retained Earnings Total Equity	-0.81	-0.47	-0.81	0.92	-0.73	-0.7	0.71	0.11	-0.49	-0.36	-0.2	0.11	0.55	-0.11	-0.8	-0.85	-0.54	-0.9	0.55	0.73	-0.48	0.55	-0.91	-0.88		-0.91
Property Plant And Equipment Gross	0.65	0.36	0.73	-0.88	0.58	0.56	-0.65	-0.15	0.38	0.24	0.06	0.01	-0.46	-0.01	0.72	0.77	0.49	0.84	-0.46	-0.66	0.55	-0.46	1.0	0.97	-0.91

Click cells to compare fundamentals

Tff Pharmaceuticals Account Relationship Matchups

Tff Pharmaceuticals fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Current Liabilities	410.6K	1.3M	2.0M	1.1M	2.4M	2.5M
Total Stockholder Equity	27.6M	37.3M	38.7M	22.9M	9.6M	9.1M
Net Tangible Assets	(3.2M)	27.6M	37.3M	38.7M	44.5M	46.8M
Retained Earnings	(15.7M)	(34.3M)	(65.3M)	(97.1M)	(118.3M)	(112.4M)
Accounts Payable	410.6K	1.3M	1.5M	919.6K	958.4K	759.2K
Total Liab	1.5M	1.3M	2.0M	1.2M	2.5M	1.3M
Total Assets	29.2M	38.7M	40.7M	24.1M	12.0M	11.4M
Cash	28.1M	35.3M	33.8M	16.6M	5.5M	5.2M
Common Stock Shares Outstanding	276.2K	817.0K	992.8K	1.2M	1.8M	1.7M
Non Current Liabilities Total	1.1M	1.3M	416.9K	110.1K	31.7K	30.2K
Net Invested Capital	27.6M	37.3M	38.7M	22.9M	9.6M	9.1M
Total Current Assets	29.2M	37.6M	38.8M	19.0M	7.6M	7.2M
Net Working Capital	28.8M	36.2M	36.9M	17.9M	5.2M	4.9M
Net Debt	(28.1M)	(35.3M)	(33.8M)	(16.4M)	(5.4M)	(5.6M)
Cash And Short Term Investments	28.1M	35.3M	33.8M	16.6M	5.5M	5.2M
Liabilities And Stockholders Equity	29.2M	38.7M	40.7M	24.1M	12.0M	20.7M
Other Current Assets	1.1M	4.5M	2.4M	2.2M	1.7M	2.2M
Other Stockholder Equity	43.3M	71.6M	104.1M	120.1M	128.0M	88.0M
Accumulated Other Comprehensive Income	(29.2M)	(51.5K)	(48.9K)	(139.3K)	(148.2K)	(155.6K)
Capital Stock	18.5K	22.5K	25.4K	36.2K	2.4K	2.3K
Common Stock	18.5K	22.5K	25.4K	36.2K	2.4K	2.3K

Pair Trading with Tff Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tff Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Tff Stock

0.68	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.85	PFE	Pfizer Inc Aggressive Push	Pair Corr

Moving against Tff Stock

0.77	FNMFO	Federal National Mortgage	Pair Corr
0.73	AVAL	Grupo Aval	Pair Corr
0.68	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.54	TRV	The Travelers Companies Fiscal Year End 17th of January 2025	Pair Corr
0.52	CIB	Bancolombia SA ADR	Pair Corr

The ability to find closely correlated positions to Tff Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tff Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tff Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tff Pharmaceuticals to buy it.

The correlation of Tff Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tff Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tff Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Tff Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Tff Stock Analysis

When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC